Safety And Efficacy Of Galcanezumab In Patients For Whom Previous Migraine Preventive Medication From Two To Four Categories Had Failed Conquer A Multicentre Randomised Double Blind Placebo Controlled Phase 3b Trial The Lancet
Lcarnitine For Eds In Narcolepsy Narcolepsy Placebo Oral
Vitamin E And Memantine For Alzheimer Disease
A Phase 2 Double Blind Placebo Controlled Randomized Study Of Fresolimumab In Patients With Steroid Resistant Primary Focal Segmental Glomerulosclerosis Kidney International Reports
Surufatinib In Advanced Pancreatic Neuroendocrine Tumours Sanet P A Randomised Double Blind Placebo Controlled Phase 3 Study The Lancet Oncology
Intra Articular Injections Of Sodium Hyaluronate Hyalgan In Osteoarthritis Of The Knee A Randomized Osteoarthritis Randomized Controlled Trial Injections
Articles Safety And Efficacy Of Adjunctive Cenobamate Ykp3089 In Patients With Uncontrolled Focal Verden Pkv Psychotherap Focal Seizure Patient Placebo
A Randomized Double Blind Placebo Controlled Study To Assess The Safety And Tolerability And Efficacy Of Pbt2 I Huntington Disease Placebo Disease
Effects Of Acarbose On Cardiovascular And Diabetes Outcomes In Patients With Coronary Heart Disease And Impaired Glucose Tolerance Ace A Randomised Double Blind Placebo Controlled Trial The Lancet Diabetes Endocrinology
Pin On Disease What Food Has To Do With It
Impact Of Sitagliptin On Endometrial Mesenchymal Stem Like Progenitor Cells A Randomised Double Blind Placebo Controlled Feasibility Trial Ebiomedicine
Food Additives And Hyperactive Behaviour In 3 Year Old And 8 9 Year Old Children In The Community A Randomised Double Blinded Placebo Controlled Trial The Lancet
Safety And Efficacy Of Metformin In Systemic Lupus Erythematosus A Multicentre Randomised Double Blind Placebo Controlled Trial The Lancet Rheumatology
Ramucirumab After Sorafenib In Patients With Advanced Hepatocellular Carcinoma And Increased A Fetoprotein Concentrations Reach 2 A Randomised Double Blind Placebo Controlled Phase 3 Trial The Lancet Oncology
Efficacy And Safety Of Guselkumab In Patients With Active Psoriatic Arthritis A Randomised Double Blind Placebo Controlled Phase 2 Study The Lancet
Remdesivir In Adults With Severe Covid 19 A Randomised Double Blind Placebo Controlled Multicentre Trial The Lancet
Safety And Immunogenicity Of The Live Attenuated Intranasal Pertussis Vaccine Bpze1 A Phase 1b Double Blind Randomised Placebo Controlled Dose Escalation Study The Lancet Infectious Diseases
Effect Of Natalizumab On Disease Progression In Secondary Progressive Multiple Sclerosis Ascend A Phase 3 Randomised Double Blind Placebo Controlled Trial With An Open Label Extension The Lancet Neurology